Sign Up | Log In | What is SocialPicks?

6 pts

Opinion on DARA Biosciences Inc. (DARA)
Fresh off the Reverse Merger

Feb 13, 2008 07:33 PM GMT

devereaux

Return	Risk
-92.92%	MID

Analyst

Profile & Performance

Subscribe to author

Coming off the reverse merger with Point Therapeutics, Dara Biosciences (DARA) has its functional IPO now. With promising drugs in its own pipeline with regards to diabetes and Parkinson's disease, in addition to its own investment in other pharma firms such as Medivation, this looks to be a promising long-term investment with an opportunity to get in at the ground floor.

DARA: This call was made on 02/13/08 @ $4.5

Rating:	$4.5 (02/13/08)
Gain/Loss:	-90.44% in 651 days
Target:	$10.00 (+122.22%) in > one year

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.25%	381
2	Gerald Greene	18.14	+72.34%	210
3	stockmarketfunding.com	17.66	+25.65%	55
4	akiralegrand	13.47	+14.32%	61
5	anup2104	12.13	+76.91%	39

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
WMT	WalMart Stores Inc
AAPL	Apple Computer Inc
F	Ford Motor Company
FSLR	First Solar Inc.
MCD	McDonald's Corp.
BA	The Boeing Company

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Until Housing Improves, Don't Expect Stocks to Rebound
by J.D. Steinhilber (Agile Investing) about SPY

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

... more »

TODAY'S TOP PICKS

CLDA		BioMed Research Reports: Clinical Data (NASDAQ: CLDA), Lpath (OTC: ... by Mike Havrilla
PARD		Biotech Stocks - Beware of The Covered Call Trap by Ivan Mutaftchiev
PBIO		Under the Radar Healthcare Stocks: Protox, Pressure BioSciences, Un... by Mike Havrilla
ISIS		ISIS - Last Tuesday's Drop Presents a Nice Buy Opportunity by Ivan Mutaftchiev
ABIO		BioMed News Bytes: Transcept, ProUroCare, SciClone, ABIO by Mike Havrilla

... more »

DARA Biosciences Inc. (DARA)

SocialPicks Sentiment: N/A

This Quarter's Sentiment:

All:

100.0%

Top:

0.0%

Get Daily Email Alerts

Subscribe to devereaux

Receive Free Ideas Daily for This Sector

Latest Picks by devereaux

Symbol	SP Sentiment	Rating	Return	Since
TMY	N/A		-95.39%	02/13/08

View All >

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Opinion on DARA Biosciences Inc. (DARA) Fresh off the Reverse Merger

Opinion on DARA Biosciences Inc. (DARA)
Fresh off the Reverse Merger